You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

FAMOTIDINE; IBUPROFEN Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Famotidine; Ibuprofen patents expire, and when can generic versions of Famotidine; Ibuprofen launch?

Famotidine; Ibuprofen is a drug marketed by Endo Operations and is included in one NDA.

The generic ingredient in FAMOTIDINE; IBUPROFEN is famotidine; ibuprofen. There are eighteen drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the famotidine; ibuprofen profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Famotidine; Ibuprofen

A generic version of FAMOTIDINE; IBUPROFEN was approved as famotidine; ibuprofen by ENDO OPERATIONS on March 22nd, 2024.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for FAMOTIDINE; IBUPROFEN?
  • What are the global sales for FAMOTIDINE; IBUPROFEN?
  • What is Average Wholesale Price for FAMOTIDINE; IBUPROFEN?
Drug patent expirations by year for FAMOTIDINE; IBUPROFEN
Paragraph IV (Patent) Challenges for FAMOTIDINE; IBUPROFEN
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
DUEXIS Tablets famotidine; ibuprofen 800 mg/26.6 mg 022519 1 2011-12-06

US Patents and Regulatory Information for FAMOTIDINE; IBUPROFEN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Endo Operations FAMOTIDINE; IBUPROFEN famotidine; ibuprofen TABLET;ORAL 203658-001 Mar 22, 2024 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.